Search research articles
Contact Us
Filters
Showing results (61-70 of 139) with videos related to
Page
of 14
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
April 2, 2020
Microenvironment-Derived FGF-2 Stimulates Renal Cell Carcinoma Cell Proliferation through Modulation of p27Kip1: Implications for Spatial Niche Formation and Functional Intratumoral Heterogeneity
Weibin Hou, Adam Kaczorowski, Philippa Lantwin, et al.
The American Journal of Pathology
|
March 26, 2016
IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2
Constanze Merz, Anne von Mässenhausen, Angela Queisser, et al.
Cancer Treatment and Research Communications
|
July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancer
Adam Kaczorowski, Xin Chen, Esther Herpel, et al.
Future Science OA
|
May 26, 2018
Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL
Svenja Dieffenbacher, Stefanie Zschäbitz, Luisa Hofer, et al.
Clinical Genitourinary Cancer
|
January 19, 2015
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center
Sonia Vallet, Sascha Pahernik, Thomas Höfner, et al.
Cancer Research
|
March 17, 2007
Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate
Ying Liu, Michelle Tseng, Sophie A Perdreau, et al.
Urologia Internationalis
|
April 27, 2022
Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year Period
Eva Bonetti, Maximilian Jenzer, Cathleen Nientiedt, et al.
Digital Health
|
May 8, 2023
An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study
Magdalena Görtz, Kilian Baumgärtner, Tamara Schmid, et al.
Cancers
|
December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma
Viktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
NPJ Precision Oncology
|
March 2, 2026
Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer
Anja Lisa Riediger, Samaneh Eickelschulte, Florian Janke, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 139) with videos related to
Sort By:
Page
of 14
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
April 2, 2020
Microenvironment-Derived FGF-2 Stimulates Renal Cell Carcinoma Cell Proliferation through Modulation of p27Kip1: Implications for Spatial Niche Formation and Functional Intratumoral Heterogeneity
Weibin Hou, Adam Kaczorowski, Philippa Lantwin, et al.
The American Journal of Pathology
|
March 26, 2016
IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2
Constanze Merz, Anne von Mässenhausen, Angela Queisser, et al.
Cancer Treatment and Research Communications
|
July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancer
Adam Kaczorowski, Xin Chen, Esther Herpel, et al.
Future Science OA
|
May 26, 2018
Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL
Svenja Dieffenbacher, Stefanie Zschäbitz, Luisa Hofer, et al.
Clinical Genitourinary Cancer
|
January 19, 2015
Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer: retrospective analysis from a large-volume cancer center
Sonia Vallet, Sascha Pahernik, Thomas Höfner, et al.
Cancer Research
|
March 17, 2007
Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate
Ying Liu, Michelle Tseng, Sophie A Perdreau, et al.
Urologia Internationalis
|
April 27, 2022
Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year Period
Eva Bonetti, Maximilian Jenzer, Cathleen Nientiedt, et al.
Digital Health
|
May 8, 2023
An artificial intelligence-based chatbot for prostate cancer education: Design and patient evaluation study
Magdalena Görtz, Kilian Baumgärtner, Tamara Schmid, et al.
Cancers
|
December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma
Viktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
NPJ Precision Oncology
|
March 2, 2026
Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer
Anja Lisa Riediger, Samaneh Eickelschulte, Florian Janke, et al.
Page
of 14